Bioinformatics

Our unique and industry-leading approach to bioinformatics is to build a core competency in a single entity that is deployed against all activities ranging from biomarker discovery through assay development and into clinical product deployment. This concentration of our expertise ensures our bioinformatics team has broad experience and skills to support an agile, modular software development approach.

The core Asuragen software incorporates a set of proprietary algorithms that enable us to extract maximal insights from results across the discovery and development continuum. Incorporation of these algorithms into our routine R&D and clinical work, coupled with a machine learning strategy, ensures they constantly evolve and remain cutting-edge. Our expert team pairs these unique algorithms with easy-to-navigate GUIs that optimize customer usability while maximizing clinically-relevant, data-to-insight results.

Features & Benefits

Our ability to create innovative bioinformatic solutions in the molecular diagnostics and research spaces, is anchored on our core capabilities and a focus on three unmet needs:

Reduced Complexity
Integrating complex analytic capabilities with our software in a “push-button”, automated data-to-insight approach significantly reduces the need for manual data interpretation.

Optimized Workflow
Our “end-to-end” approach to product development ensures software is tailored to support our chemistries and simplifies end-user experience, dramatically reducing hands-on and training time.

Quality Performance
Our Reporter software solutions combine machine-learning algorithms with integrated QC capabilities and run metrics to enable automatic and accurate result calling. Our proprietary Sample-Aware capabilities ensure constant result quality monitoring and reduce false positive results while highlighting false negative risk.

Reporter Software

QuantideX® NGS Reporter

Our QuantideX NGS Reporter software uses a machine-learning algorithm, and is trained to be Sample-Aware, optimizing results as a function of sample input quality. This enables increased sensitivity and reduces the false positive rate in high quality samples, while highlighting false negative risk in low quality samples. Automated analysis further reduces the need for subjective interpretations.

Push-button analytics & reporting suite | Set up and go workflow designed for easy installation and implementation, right out of the box.

Runs directly on lab desktop | Install locally on a standard Windows® desktop computer. No prior bioinformatics experience or large server environments required.

Comprehensive reporting | Full bioinformatics and reporting of variants (SNPs and indels), and standard QC metrics are automatically calculated.

Integrates QuantideX qPCR DNA QC Assay | Sample-Aware™ bioinformatics that factor in functional template copy number, dramatically reducing false call rates.

Seamless updates offered with new panel designs & variant annotation | Software updates allow new panels to be adopted without re-investing in analytics when incorporating Asuragen QuantideX NGS panels.

Contact us to request the QuantideX Reporter

AmplideX® PCR/CE FMR1 Reporter

The AmplideX PCR/CE FMR1 Reporter provides highly accurate FMR1 sizing with automatic and robust size calibration, elimination of noise artifacts and the integration of batch-level QC and run metrics.

Learn more about AmplideX PCR/CE FMR1 Reporter

Case Studies

Case Study 1. AmplideX® PCR/CE FMR1 Reporter*
Automated fragment size analysis of AmplideX® FMR1 PCR products improves interpretive accuracy and reduces turn-around time. Learn more

Case Study 2. An Integrated System for Targeted NGS*
Enabling simultaneous analysis of DNA mutations, RNA fusions and gene expression in residual clinical FFPE and FNA specimens. Learn more

Case Study 3. QuantideX® NGS Reporter*
A push-button bioinformatics analysis tool that integrates pre-analytic QC for simple-to-use analytics with superior variant detection in residual clinical FFPE, FNA, and liquid tumor biopsies. Learn more

*For Research Use Only. Not for use in diagnostic procedure

Bioinformatics

Our unique and industry-leading approach to bioinformatics is to build a core competency in a single entity that is deployed against all activities ranging from biomarker discovery through assay development and into clinical product deployment. This concentration of our expertise ensures our bioinformatics team has broad experience and skills to support an agile, modular software development approach.

The core Asuragen software incorporates a set of proprietary algorithms that enable us to extract maximal insights from results across the discovery and development continuum. Incorporation of these algorithms into our routine R&D and clinical work, coupled with a machine learning strategy, ensures they constantly evolve and remain cutting-edge. Our expert team pairs these unique algorithms with easy-to-navigate GUIs that optimize customer usability while maximizing clinically-relevant, data-to-insight results.

Features & Benefits

Our ability to create innovative bioinformatic solutions in the molecular diagnostics and research spaces, is anchored on our core capabilities and a focus on three unmet needs:

Reduced Complexity
Integrating complex analytic capabilities with our software in a “push-button”, automated data-to-insight approach significantly reduces the need for manual data interpretation.

Optimized Workflow
Our “end-to-end” approach to product development ensures software is tailored to support our chemistries and simplifies end-user experience, dramatically reducing hands-on and training time.

Quality Performance
Our Reporter software solutions combine machine-learning algorithms with integrated QC capabilities and run metrics to enable automatic and accurate result calling. Our proprietary Sample-Aware capabilities ensure constant result quality monitoring and reduce false positive results while highlighting false negative risk.

Reporter Software

QuantideX® NGS Reporter

Our QuantideX NGS Reporter software uses a machine-learning algorithm, and is trained to be Sample-Aware, optimizing results as a function of sample input quality. This enables increased sensitivity and reduces the false positive rate in high quality samples, while highlighting false negative risk in low quality samples. Automated analysis further reduces the need for subjective interpretations.

Push-button analytics & reporting suite | Set up and go workflow designed for easy installation and implementation, right out of the box.

Runs directly on lab desktop | Install locally on a standard Windows® desktop computer. No prior bioinformatics experience or large server environments required.

Comprehensive reporting | Full bioinformatics and reporting of variants (SNPs and indels), and standard QC metrics are automatically calculated.

Integrates QuantideX qPCR DNA QC Assay | Sample-Aware™ bioinformatics that factor in functional template copy number, dramatically reducing false call rates.

Seamless updates offered with new panel designs & variant annotation | Software updates allow new panels to be adopted without re-investing in analytics when incorporating Asuragen QuantideX NGS panels.

Contact us to request the QuantideX Reporter

AmplideX® PCR/CE FMR1 Reporter

The AmplideX PCR/CE FMR1 Reporter provides highly accurate FMR1 sizing with automatic and robust size calibration, elimination of noise artifacts and the integration of batch-level QC and run metrics.

Learn more about AmplideX PCR/CE FMR1 Reporter

Case Studies

Case Study 1. AmplideX® PCR/CE FMR1 Reporter*
Automated fragment size analysis of AmplideX® FMR1 PCR products improves interpretive accuracy and reduces turn-around time. Learn more

Case Study 2. An Integrated System for Targeted NGS*
Enabling simultaneous analysis of DNA mutations, RNA fusions and gene expression in residual clinical FFPE and FNA specimens. Learn more

Case Study 3. QuantideX® NGS Reporter*
A push-button bioinformatics analysis tool that integrates pre-analytic QC for simple-to-use analytics with superior variant detection in residual clinical FFPE, FNA, and liquid tumor biopsies. Learn more

*For Research Use Only. Not for use in diagnostic procedure

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close